Department News | October 29, 2026
The Garvey Institute for Brain Health Solutions has selected 10 individuals who will form the first cohort of clinicians in the new Chopp Scholars Program in Behavioral Health Policy. Chopp Policy Scholars will be paired with legislators and other policy mentors to learn about behavioral health policy, to develop practical skills and connections, and to help advance behavioral health policy in Washington state.
Department news | October 27, 2026
The UW Medicine Garvey Institute for Brain Health Solutions is funding twelve new projects that will address one of the following areas of focus: behavioral healthcare during the perinatal period, creating therapeutic communities for those living with serious mental illnesses, leveraging artificial intelligence for workforce development, mental health and the law, and neuromodulation. “We are […]
The Daily | October 20, 2026
"When deciding whether a candidate is ready to advance, selectivity, safety, and manufacturability are three essential considerations," says Marco Pravetoni, PhD.
Axios Seattle | October 5, 2026
Marco Pravetoni, PhD hopes the vaccine can be used alongside medication-assisted treatments including buprenorphine and methadone.
Department News | September 24, 2026
By integrating AI, experimental science, and interdisciplinary training, the UW School of Pharmacy’s new Institute for Innovations in Drug Disposition and Delivery (I2D3) will accelerate drug discovery and improve how medicines are manufactured (or formulated) and delivered, ensuring they reach the right place in the body with greater safety, effectiveness, and precision.
King5 News | September 23, 2026
“People retire early, they're out more on medical leave, or they choose not to get into the profession at all because they've heard negative things,” said Mandy Owens, PhD.
Department News | September 23, 2026
In August 2026, the U.S. Department of Veterans Affairs announced the launch of a new clinical trial to evaluate the effectiveness and safety of psilocybin to treat major depression in Veterans, including those with concurrent post-traumatic stress disorder.
Department News | September 23, 2026
Over the past two years, four Washington communities came together through the Youth Wellness Zones Collaborative to explore a neighborhood-first approach to advancing youth mental health and wellbeing.
Department News | September 23, 2026
On September 2, 2026, the Psychiatry Residency Program completed the long‑awaited ACGME accreditation site visit, a four‑hour virtual marathon with residents, faculty, leadership, staff, and key partners across GME.
Department News | September 23, 2026
This summer, the Addictions, Drug & Alcohol Institute (ADAI) launched a new eight-week internship program for UW undergraduate students with an interest in working in substance use/addictions, public health, science communications, and related fields.
